ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1147

Development of a Digital Toolkit to Improve Quality of Life of Patients with Systemic Lupus Erythematosus: A Pilot Study

Jerik Leung1, Ashish Shrestha1, Jennifer Ra2, Laura Brennan3, Alfred Kim4 and Elizabeth Baker1, 1Saint Louis University, College for Public Health and Social Justice, St. Louis, 2Washington University School of Medicine, Lake Forest, CA, 3Transtria, St. Louis, 4Washington University School of Medicine, St. Louis, MO

Meeting: ACR Convergence 2020

Keywords: Community programs, education, patient, Qualitative Research, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Individuals living with systemic lupus erythematosus (SLE) face a number of challenges in managing their condition. Initial interviews and community forums with SLE patients suggested that unpredictability and variability of symptoms contribute to the erosion of formal and informal social support and highlighted the need for information and skills to adapt to symptom fluctuations. Patients suggested that digital tools may be particularly well suited to addressing these unmet needs because symptom unpredictability reduces the ability to reliably attend in-person interventions. The purpose of this project was to use patient-centered outcomes research (PCOR) and community-based participatory research (CBPR) principles of practice to engage stakeholders including SLE patients, patient advocacy organizations, and providers to prioritize unmet needs and to develop resources to address those needs.

Methods: Initial recommendations for content priorities and methods of delivery were developed through a series of stakeholder meetings (patients, health care providers, representatives from community-based organizations) and a mixed-methods survey of SLE patients evaluating internet usage and access. A clickable prototype of the digital toolkit was then developed incorporating priority content areas. Alpha (individuals with no affiliation with SLE clinic) and beta (patients and family members, health care providers, clinical staff) usability assessments of the clickable prototype were conducted through semi-structured interviews.

Results: Content areas identified as priorities included: nutrition, improving communication (family/friends and health care providers), physical activity, and self-management. Respondents provided a number of suggestions based on their review of our toolkit and experiences with existing SLE resources. Respondents emphasized the benefits of digital access to this content (website, smartphone application). Given the variability of SLE experiences, respondents desired the ability to regularly visit the platform, to receive tailored messages which would guide them to relevant information, and to conduct open searches of the material. Key suggestions for improving the platform included a sign-in for users to track activity, a live chat with SLE experts, a variety of static and dynamic virtual tools, and an ability to connect with other SLE patients.

Conclusion: Individuals living with SLE have dynamic needs that change over time. Digital platforms were identified by stakeholders as a viable way to respond to these dynamic needs since they can be easily accessed and tailored to individuals. Community-based/patient-centered approaches ensure that the perspectives of those who are affected most by a problem are included in intervention design.


Disclosure: J. Leung, None; A. Shrestha, None; J. Ra, None; L. Brennan, BJC Healthcare, 3; A. Kim, Exagen Diagnostics, Inc., 5, 8, GlaxoSmithKline, 2, 5, 8, Alexion Pharmaceuticals, 5, Annexon Biosciences, 5, JPMorgan Chase & Co., 5; E. Baker, None.

To cite this abstract in AMA style:

Leung J, Shrestha A, Ra J, Brennan L, Kim A, Baker E. Development of a Digital Toolkit to Improve Quality of Life of Patients with Systemic Lupus Erythematosus: A Pilot Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/development-of-a-digital-toolkit-to-improve-quality-of-life-of-patients-with-systemic-lupus-erythematosus-a-pilot-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-digital-toolkit-to-improve-quality-of-life-of-patients-with-systemic-lupus-erythematosus-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology